Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-25

FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved Upsher-Smith Laboratories' supplemental application for ZESTRIL (lisinopril), resulting in approved labeling changes. Lisinopril is used to tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zestril (lisinopril)

Snippet

SUPPL AP for ZESTRIL (LISINOPRIL)